Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Westerpharma Oy
OY
Active
Y-tunnus 3146365-7
Orapihlajantie 12, 02620
Espoo
Retail sale of medical and orthopaedic goods
·
NACE 4774
Est. 2020 · 5 years old
— employees
Share
Finland
/
Companies
/
Retail sale of medical and orthopaedic goods
/
Westerpharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
416
740
635
610
615
Staff expenses
—
—
−0
−0
−0
EBITDA
106
218
197
187
191
Depreciation & amort.
—
—
−0
−0
−0
EBIT
106
218
197
187
191
Net financials
—
0
−0
7
14
Profit before tax
106
218
197
195
205
Tax
21
44
39
39
41
Net profit
85
175
158
156
164
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
148
309
459
561
681
Equity
112
278
413
536
657
Long-term debt
—
—
0
0
0
Short-term debt
37
31
46
25
24
Total debt
37
31
46
25
24
Financial ratios
5-year trend
EBITDA-margin
31.0%
This company
15.8%
Market median
+96% vs market
2021
2025
Soliditetsgrad
96.5%
This company
38.2%
Market median
+153% vs market
2021
2025
Egenkapitalforrentning
25.0%
This company
18.4%
Market median
+36% vs market
2021
2025
Nettoresultatgrad
26.6%
This company
8.1%
Market median
+228% vs market
2021
2025
Aktivomsætning
0.90×
This company
1.12×
Market median
+20% vs market
2021
2025
Gæld/egenkapital
0.04×
This company
0.62×
Market median
+94% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Westerpharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
